Provided by Tiger Trade Technology Pte. Ltd.

Inventiva S.A.

3.69
+0.400012.16%
Post-market: 3.700.0100+0.27%18:47 EDT
Volume:4.80M
Turnover:17.76M
Market Cap:870.84M
PE:-3.51
High:3.93
Open:3.51
Low:3.46
Close:3.29
52wk High:7.98
52wk Low:3.11
Shares:236.00M
Float Shares:180.00M
Volume Ratio:1.62
T/O Rate:2.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0514
EPS(LYR):-2.2308
ROE:-989.05%
ROA:-42.68%
PB:13.03
PE(LYR):-1.65

Loading ...

Inventiva (IVA) Receives a Rating Update from a Top Analyst

TIPRANKS
·
Yesterday

Inventiva is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Yesterday

Analysts Have Conflicting Sentiments on These Healthcare Companies: Roche Holding AG (OtherRHHVF), Adagene (ADAG) and Inventiva (IVA)

TIPRANKS
·
Sep 29

Inventiva price target raised to $21 from $20 at Canaccord

TIPRANKS
·
Sep 29

Analysts Offer Insights on Healthcare Companies: Inventiva (IVA) and Moderna (MRNA)

TIPRANKS
·
Sep 29

France's Inventiva H1 Net Loss Narrows

Reuters
·
Sep 28

Inventiva H1 EPS $(0.29) Misses $(0.20) Estimate, Sales $23.251K Miss $10.000M Estimate

Benzinga Earnings
·
Sep 28

Inventiva SA Expected to Post a Loss of 49 Cents a Share - Earnings Preview

Reuters
·
Sep 26

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Celldex (CLDX) and Inventiva (IVA)

TIPRANKS
·
Sep 23

Analysts Offer Insights on Healthcare Companies: Surgery Partners (SGRY), Envista Holdings (NVST) and Inventiva (IVA)

TIPRANKS
·
Sep 18

Inventiva Currently Down 10 Consecutive Days, on Pace for Longest Losing Streak

Dow Jones
·
Sep 17

Analysts Have Conflicting Sentiments on These Healthcare Companies: SanBio Co (OtherSNBIF), Immutep Ltd (OtherPRRUF) and Inventiva (IVA)

TIPRANKS
·
Sep 15

Inventiva price target raised to $14 from $11 at Guggenheim

TIPRANKS
·
Sep 15

Guggenheim Sticks to Its Buy Rating for Inventiva (IVA)

TIPRANKS
·
Sep 15

Inventiva Says All Patients Completed 72-Week Treatment Period in Phase 3 Liver Disease Study

MT Newswires Live
·
Sep 03

Inventiva announces last patient visit in NATiV3 trial

TIPRANKS
·
Sep 03

Inventiva Names Chris Benecchi COO

MT Newswires Live
·
Sep 01

Inventiva appoints Chris Benecchi as COO

TIPRANKS
·
Sep 01

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jul 27

Inventiva Initiated at Overweight by Cantor Fitzgerald

Dow Jones
·
Jul 17